Talphera, Inc. Common Stock
Symbol: TLPH (NASDAQ)
0.99
▲ (16.35%) 0.139
Company Description:
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Key Stats
- Today's Open: $0.864
- Today's High: $1.015
- Today's Low: $0.825
- Today's Volume: 1.44M
- Yesterday Close: $0.85
- Yesterday High: $0.89
- Yesterday Low: $0.8144
- Yesterday Volume: 581.14K
- Last Min Volume: 100
- Last Min High: $0.989
- Last Min Low: $0.98
- Last Min VWAP: $0.98
Company Profile
- Name: Talphera, Inc. Common Stock
- Website: https://www.talphera.com
- Listed Date: 2011-02-11
- Location: SAN MATEO, CA
- Market Status: Active
- CIK Number: 0001427925
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $17.44M
- Round Lot: 100
- Outstanding Shares: 20.52M
- Asset Type: CS
RECENT FILINGS FOR TLPH
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-10 | 8-K | View |
| 2025-09-09 | DEFA14A | View |
| 2025-09-09 | DEF 14A | View |
| 2025-08-29 | PRE 14A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-06-05 | 8-K | View |
| 2025-05-21 | 4 | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-14 | 8-K | View |
| 2025-05-12 | EFFECT | View |
| 2025-05-12 | 424B7 | View |
| 2025-05-09 | CORRESP | View |
| 2025-05-08 | UPLOAD | View |
| 2025-05-02 | S-3 | View |
| 2025-04-29 | 10-K/A | View |
| 2025-04-17 | D | View |
| 2025-04-11 | SCHEDULE 13G | View |
| 2025-04-03 | SCHEDULE 13D/A | View |
| 2025-04-03 | 4 | View |
Latest News on TLPH